A genetic variant associated with aquaporin 3 expression is correlated to in-hospital death in COVID-19 patients with extracellular hyperosmolality
Physiological Genomics · 2025
DOI: 10.1152/physiolgenomics.00174.2024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Genomics, 2025. Verfasst von Michael Marks-Hultström und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: Aquaporin 3, COVID-19, Hospital Mortality, Polymorphism, Single Nucleotide. Die Arbeit nennt 23 Literaturangaben. Gefördert von: Canadian Government | Canadian Institutes of Health Research (CIHR), JGH | Lady Davis Institute for Medical Research (LDI), Canadian Foundation for Innovation.
Abstract (Originalsprache)
A genetic variant near water channel AQP3, linked to severe COVID-19, amplifies the risk of death in patients with elevated plasma osmolality. In patients hospitalized with COVID-19, we show that although the variant does not affect systemic osmolality directly, it interacts with hyperosmolality to increase mortality risk. These findings highlight a potential mechanism where AQP3 overexpression disrupts cellular water handling during critical illness, offering new insight into the role of water balance in COVID-19 pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Anaesthesiology and Intensive Care Medicine, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
- Division of Integrative Physiology, Department of Medical Cell Biology, Uppsala University, Uppsala, Sweden.
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Québec, Canada.
- Lady Davis Institute of Medical Research, Jewish General Hospital, McGill University, Montréal, Québec, Canada.
- Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden.
- Department of Human Genetics, McGill University, Montréal, Québec, Canada.
ORCID-Profile: Michael Marks-Hultström, Amanda M Marks, Hugo Zeberg
Förderung
- Canadian Government | Canadian Institutes of Health Research (CIHR)
- JGH | Lady Davis Institute for Medical Research (LDI)
- Canadian Foundation for Innovation
- NIH Foundation
- Cancer Research UK (CRUK)
- Genome Quebec
- Public Agency of Health of Canada
- Fonds de Recherche Québec Santé
Zitieren
APA
Marks-Hultström, M., Marks, A. M., Butler-Laporte, G., Yoshiji, S., Lu, T., Morrison, D. R., Nakanishi, T., Chen, Y., Forgetta, V., Farjoun, Y., Frithiof, R., Lipcsey, M., Zeberg, H., & Richards, J. B. (2025). A genetic variant associated with aquaporin 3 expression is correlated to in-hospital death in COVID-19 patients with extracellular hyperosmolality. Physiological Genomics. https://doi.org/10.1152/physiolgenomics.00174.2024
Vancouver
Marks-Hultström M, Marks AM, Butler-Laporte G, Yoshiji S, Lu T, Morrison DR, et al. A genetic variant associated with aquaporin 3 expression is correlated to in-hospital death in COVID-19 patients with extracellular hyperosmolality. Physiological Genomics. 2025. doi:10.1152/physiolgenomics.00174.2024
BibTeX
@article{MarksHultstrm2025,
author = {Marks-Hultström, Michael and Marks, Amanda M and Butler-Laporte, Guillaume and Yoshiji, Satoshi and Lu, Tianyuan and Morrison, Dave R and Nakanishi, Tomoko and Chen, Yiheng and Forgetta, Vincenzo and Farjoun, Yossi and Frithiof, Robert and Lipcsey, Miklos and Zeberg, Hugo and Richards, J Brent},
title = {A genetic variant associated with aquaporin 3 expression is correlated to in-hospital death in COVID-19 patients with extracellular hyperosmolality},
journal = {Physiological Genomics},
year = {2025},
doi = {10.1152/physiolgenomics.00174.2024}
}
EUVIMED